BioArctic revenue and financials
kr 301.20Change from previous close: −1.31%Absolute change: −kr 4.00
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 1,999 | 257 | 616 | 228 | — |
| Cost of revenue | 59.2 | 27.0 | 15.0 | 74.3 | — |
| Gross profit | 1,940 | 230 | 601 | 154 | — |
| Selling, general and administrative | 195 | 149 | 172 | — | 24.9 |
| Research and development | 377 | 311 | 172 | — | — |
| Operating income | 1,368 | -230 | 257 | -7.9 | — |
| EBIT | 1,258 | -190 | 277 | -10.6 | — |
| EBITDA | 1,270 | -179 | 284 | 4.0 | — |
| Interest expense | 2.0 | 0.0 | 0.3 | 0.6 | — |
| Pre-tax income | 1,256 | -190 | 276 | -11.2 | — |
| Income tax | 233 | -12.4 | 47.2 | 0.0 | — |
| Net income | 1,022 | -177 | 229 | -11.2 | — |
| Net income to common shareholders | 1,022 | -177 | 229 | -11.2 | — |
| Basic EPS | 11.55 | -2.00 | 2.60 | -0.13 | — |
| Diluted EPS | 11.52 | -2.00 | 2.59 | -0.13 | — |
| Average shares (basic) | 88.5 | 88.3 | 88.2 | 88.1 | — |
| Average shares (diluted) | 88.7 | 88.5 | 88.5 | 88.7 | — |